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Objective: The aim of this study is to clarify the role of regulatory T cell (Treg) in triptolide
(TP)-induced hepatotoxicity.
Methods: Female C57BL/6 mice received either adoptive transfer of Tregs or depletion
of Tregs, then underwent TP administration and were sacrificed 24 h after TP
administration. Liver injury was determined according to alanine transaminase (ALT)
and aspartate transaminase (AST) levels in serum and histopathological change in liver
tissue. Hepatic frequencies of Treg cells and the mRNA expression levels of transcription
factor Forkhead box P3 and retinoid orphan nuclear receptor γt (RORγt), interleukin-
10 (IL-10), suppressor of cytokine signaling (SOCS), and Notch/Notch ligand were
investigated.
Results: During TP-induced liver injury, hepatic Treg and IL-10 decreased, while T
helper 17 cells cell-transcription factor RORγt, SOCS and Notch signaling increased,
accompanied with liver inflammation. Adoptive transfer of Tregs ameliorated the severity
of TP-induced liver injury, accompanied with increased levels of hepatic Treg and IL-
10. Adoptive transfer of Tregs remarkably inhibited the expression of RORγt, SOCS3,
Notch1, and Notch3. On the contrary, depletion of Treg cells in TP-administered mice
resulted in a notable increase of RORγt, SOCS1, SOCS3, and Notch3, while the Treg
and IL-10 of liver decreased. Consistent with the exacerbation of liver injury, higher
serum levels of ALT and AST were detected in Treg-depleted mice.
Conclusion: These results showed that adoptive transfer or depletion of Tregs
attenuated or aggravated TP-induced liver injury, suggesting that Tregs could play
important roles in the progression of liver injury. SOCS proteins and Notch signaling
affected Tregs, which may contribute to the pathogenesis of TP-induced hepatotoxicity.
Keywords: regulatory T cell (Treg), triptolide, interleukin-10, hepatotoxicity, adoptive transfer of Tregs, depletion
of Tregs, suppressor of cytokine signaling (SOCS), notch signaling
Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase; Dll, delta-like; ELISA, enzyme linked
immunosorbent assay; FoxP3, Forkhead box P3; H&E, hematoxylin and eosin; IL-10, interleukin-10; MNC, mononuclear
cell; RORγt, retinoid orphan nuclear receptor γt; SOCS, suppressor of cytokine signaling; STAT, signal transducers and
activators of transcription; Th17 cells, T helper 17 cells; TP, triptolide; Treg cells, regulatory T cells; TWHF, Tripterygium
wilfordii Hook F.
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INTRODUCTION
Triptolide is isolated from the traditional Chinese medicine
TWHF, which exhibits notable immune-regulative effects (Liu,
2011). TP has demonstrated a promising effect on the treatment
of renal transplantation and autoimmune diseases in animal
models by regulation of Tregs (Li et al., 2010; Zhou et al., 2011).
Despite the benefits it provides, acute overdose or long-term
administration of TP can cause severe liver injury and even death
(Fu et al., 2011). The occurrence of drug-induced liver injury is
a major problem in all phases of clinical drug development. In
most cases, the mechanism of TP-induced hepatic injury remains
unclear.
Several reports have showed that Tregs play an important
role in liver disorders (Sennello et al., 2005; Stross et al., 2012).
Treg maintains immune homeostasis by suppressing excessive
immune responses which otherwise would result in serious
tissue damage (Kim et al., 2007). FoxP3 is characterized as
a transcription factor required for Treg development (Yagi
et al., 2004). IL-10 is produced by Tregs and other cell
types. IL-10 is crucial for preventing exaggerated inflammation
and thus protecting the host from immune-mediated damage
(Sabat et al., 2010). The liver is an organ of complex
immune responses and mainly provides protection by tolerating
harmless self and foreign antigens (Doherty and O’Farrelly,
2000). When tolerance is broken, activated immune cells
induce liver injury and hepatic inflammation by releasing pro-
inflammatory cytokines and chemokines, which determines
the extent of liver injury (Wang et al., 2015). Accumulating
evidence suggests that anti-inflammatory Treg cells and pro-
inflammatory Th17 cells have antagonistic effects on the
progression of liver injury (Li et al., 2012). Therefore, it is
critical to modulate the immune homeostasis during liver
injury. Although the decrease of Tregs in liver injury has been
reported (Wang et al., 2014a), the involvement of Tregs in
noninfectious hepatic injury, such as TP-induced liver injury,
has not been investigated. The purpose of this study is to
identify the involvement of Treg cells in TP-induced liver
injury.
Suppressor of cytokine signaling proteins play a crucial role
in preventing the cytokine responses and maintaining organ
homeostasis. They are negative regulators of the JAK/STAT
signaling pathway (Yoshimura et al., 2007). Eight SOCS proteins,
SOCS1–SOCS7 and cytokine-inducible SH2-containing protein-
1 (CIS-1) have been identified, of which SOCS1, 2, and 3 are
the best characterized. Tregs are deficient in SOCS3 protein
expression, which is needed for Treg to rapidly respond to
cytokines to prevent unwarranted immune responses to self-
antigens (Pillemer et al., 2007). The Notch signaling pathway
control cell-fate decisions in T-cell development in the thymus
and T-cell differentiation in the periphery (Deftos and Bevan,
2000). In mammals, there are four Notch receptors-Notch1–
4 and five Notch ligands-Jagged-1 and -2 and Dll-1, -3,
and -4 (Radtke et al., 2010). The Notch family contributes
to induction of Treg cells and suppression of autoimmune
diseases (Burghardt et al., 2014). Because SOCS and Notch
signaling modulate differentiation and proliferation of T-helper
(Th) cells. The second purpose of this study is to investigate the
expression of SOCS and Notch/Notch ligands in TP-induced liver
injury.
Our previous investigations have reported that hepatic Treg
and IL-10 decreased in TP-induced liver injury (Wang et al.,
2014a), yet it has been unknown about the potential mechanisms
regulating Tregs in TP-induced hepatotoxicity. In the present
study, the percentage and phenotypic features of Tregs in
the livers of mice were examined. The expression of SOCS
proteins and Notch signaling were investigated. Either adoptive
transfer or depletion of Tregs was conducted to investigate
Tregs’ roles in TP-induced liver injury. These results may
lead to useful therapeutic approaches for TP-induced liver
injury.
MATERIALS AND METHODS
Chemicals
Triptolide (purity >98%) was a gift from the Dermatological
Disease Research Institute of the Chinese Academy of Medical
Sciences (Nanjing, China). TP was reconstituted in propylene
glycol and stored at −20◦C. Then, TP was freshly diluted to the
appropriate concentrations with a 0.2% carboxymethylcellulose
solution before use in the experiments.
Animals and Treatment
Female C57BL/6 mice, 6–8 weeks of age, were purchased
from the Vital River Experimental Animal Technology, Co.,
Ltd. (Beijing, China). All of the mice were housed under
pathogen-free conditions and were provided with mouse chow
and water ad libitum. The animals were maintained at a
controlled temperature (22◦ ± 2◦C) and photoperiod (12 h of
light and 12 h of dark). The animals were acclimated to the
laboratory for 1 week before the experiments. This study was
approved by the Ethical Committee of China Pharmaceutical
University, and Laboratory Animal Management Committee
of Jiangsu Province (Approval No.: 2110748). The animal
experiments were carried out in accordance with the approved
guidelines.
The mice were divided randomly into five groups
(n = 12/group): (i) vehicle-treated control group, in which
mice were given 0.2% carboxymethylcellulose solution (i.g.)
at 24 h prior to sacrifice; (ii) TP group, in which mice
were given TP (500 µg/kg, i.g.) at 24 h before sacrifice; (iii)
adoptive transfer of Treg-pretreated TP group, in which
mice were given CD4+CD25+Tregs (1 × 106, i.v.) at 24 h
before TP administration, then underwent TP administration
and sacrifice at 24 h after TP administration; (iv) adoptive
transfer of Teff-pretreated TP group, in which mice were
given CD4+CD25−Teffs (1 × 106, i.v.) at 24 h before TP
administration, then underwent TP administration and sacrifice
at 24 h after TP administration; (v) anti-CD25-pretreated TP
group, in which mice were given purified anti-CD25 antibodies
(200 µg, i.p., clone: PC61) at 48 h before TP administration
(Tenorio et al., 2010), then underwent TP administration and
sacrifice at 24 h after TP administration.
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Cell Purification
Mouse CD4+CD25+Tregs and CD4+CD25−Teffs were isolated
from the spleen with a MACS Treg isolation kit (Miltenyi Biotec,
Auburn, CA, USA). The purity of the Treg cell was above 90%, as
assessed by flow cytometry.
Blood Chemistry Aanalysis
The blood was collected in tubes without anticoagulant to obtain
serum which was analyzed for the level of ALT and AST by
using an automatic clinical analyzer (7080, HITACHI Ltd, Tokyo,
Japan).
Histopathological Evaluations
Sections from the livers were removed and fixed in 10% neutral-
buffered formalin. For the histopathological examination, all
of the fixed organs were processed for embedding in paraffin,
sectioned, and stained with H&E.
MNC Isolation and Labeling
Murine livers were passed through a 200-gage nylon mesh,
and washed with cold PBS. The cell mixture was centrifuged
at 50 × g for 2 min. The supernatant was then centrifuged
at 800 × g for 10 min. For hepatic MNC isolation, the cell
pellets were resuspended in 40% Percoll and centrifuged at
1250 × g for 15 min. Then the cell pellets were treated
with lysis solution to remove erythrocytes and obtain hepatic
MNCs. Next, cells were blocked with anti-CD16/32 (Becton
Dickinson, San Diego, CA, USA) and labeled with anti-mouse
CD4 antibodies (Becton Dickinson) before permeabilization
with Cytoperm/Cytofix (Becton Dickinson) according to the
manufacturer’s instructions. After permeabilization, the cells
were incubated with labeled antibodies that were specific for
FoxP3 (Becton Dickinson). Then, the cells were centrifuged, and
the pellets were washed to remove unbound antibodies. After
surface and intracellular labeling, MNCs were evaluated by flow
cytometry (Calibrate; Becton Dickinson, Palo Alto, CA, USA)
and the data were analyzed using FlowJo version 10 software
(FlowJo, Ashland, OR, USA).
RNA Extraction and Real-time PCR
RNA was isolated from the liver sections with TRIzol reagent
(Invitrogen Life Technologies, Carlsbad, CA, USA). CDNA
synthesis was performed under manufacturer’s instructions by
using the RevertAid First Strand cDNA Synthesis kit (Thermo
Scientific, Waltham, MA, USA). Real-time PCR was performed
in a 20-µL system which contained 10 µL of 1× SYBR Green
Master Mix (Vazyme Biotech, Nanjing, China), 2 µL of cDNA,
6 µL of RNase/DNase-free water and 500 nM of each primer.
The thermal cycler conditions included holds for 30 s at 95◦C,
followed by 40 cycles of 5 s at 95◦C and 10 s at 60◦C. A melting
curve analysis was performed for each reaction with a 65–95◦C
ramp. The threshold cycle at which the fluorescent signal reached
an arbitrarily set threshold near the middle of the log-linear phase
of the amplification for each reaction was calculated, and the
relative quantity of mRNA were determined. The mRNA levels
were normalized against the mRNA levels of the housekeeping
gene GAPDH. The primer sequences used were shown in
Table 1.
Detection of Cytokines by ELISA
Serum was used to determine the concentrations of IL-10 by
ELISA (RayBio, Norcross, GA, USA) in accordance with the
manufacturer’s protocol.
Statistical Analysis
The data were expressed as the mean ± SEM. The groups were
evaluated using a one-way analysis of variance (ANOVA) and
Turkey’s t-test. P-values <0.05 were considered to be statistically
significant.
TABLE 1 | Primers for real-time RT-PCR.
Gene Forward primer (5′–3′) Reverse primer (5′–3′)
GAPDH CTTTGGCATTGTGGAAGGGCTC GCAGGGATGATGTTCTGGGCAG
FoxP3 CACCCAGGAAAGACAGCAACC CTCGAAGACCTTCTCACAACCA
ROR-γt TCCATATTTGACTTTTCCCACT GATGTTCCACTCTCCTCTTCTC
IL-10 TGAAGACCCTCAGGATGCGG AGAGCTCTGTCTAGGTCCTGG
SOCS1 GAGTGGTTGTGGAGGGTGAGA TGGTTTGTGCAAAGATACTGGGAAT
SOCS2 CCTGGGGTTCAGTCTGTGTTAG TGGTGATGGTTCTTTTTTCGTTTCT
SOCS3 GAGAGCGGATTCTACTGGAGCG ACTGGATGCGTAGGTTCTTGGTC
Notch1 CCTTCGTGCTCCTGTTCTTTGTG GGGCTCTCTCCGCTTCTTCTTG
Notch2 ACAAGTGAAGTGCAGGAGAGGGG CAGCGGCAGGAATAGTGAGGAG
Notch3 CTCTGTGGTGATGCTGGAGATTGA TGCTGACAAGGCTCCCAGGTAG
Notch4 GACACTCCACCTTTCATCTCTG GGCTTCACATTCATCTATATCTTCA
Jagged1 GCTTCTCACTCAGGCATGATAAACC CCATAGTAGTGGTCATCACAGGTCA
Jagged2 CAGGGCAAGTTCTGTGACGAGTG CAGGCTCAGCATTGATGCAGGT
Dll-1 TATCTCCTTTCTCCTCTTTCCCTCC CAACTTTCGGTTTCCTCTTCGTCT
Dll-3 TGAAACCTCTGGCTCCTTTGAATG GGTCCACCCTCTTCTCACAGTTA
Dll-4 AATCAGCTTTTCAGGAACTCGGC ATCCCTTGGGGTGTCCTCTCC
FoxP3, Forkhead box P3.
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FIGURE 1 | Adoptive transfer of Tregs alleviates TP-induced liver injury. The mice were administered with CD4+CD25+Tregs or CD4+CD25−effector T cells
(1 × 106; i.v.) 24 h before TP administration, then underwent TP administration (500 µg/kg; i.g.) and sacrificed 24 h after TP administration. Changes of serum ALT
(A) and AST (B) levels were measured. Liver specimens were excised and fixed in 10% neutral-buffered formalin to generate tissue sections stained with H&E (C).
The data are shown as the mean ± SEM of six mice. ∗P < 0.05 and ∗∗P < 0.01 vs. control. #P < 0.05, ##P < 0.01, and ###P < 0.001 vs. TP group. Black arrows
shows necrosis and yellow arrows shows inflammatory cell infiltration.
RESULTS
Adoptive Transfer of Tregs Ameliorates
TP-induced Liver Injury
The results demonstrated that ALT and AST levels significantly
increased 24 hours after TP administration (Figures 1A,B).
Histopathological changes in livers after TP administration
showed necrosis with inflammatory cell infiltrating in
hepatocytes (Figure 1C). However, adoptive transfer of
Treg cells exhibited significantly lower levels of ALT and AST
(Figures 1A,B) and ameliorated necrosis and inflammatory
cell infiltrating in the liver (Figure 1C). Furthermore, adoptive
transfer of Teffs reduced the TP-induced increase of AST, but
didn’t display more obvious alleviation of TP-induced liver
injury. These findings demonstrated that adoptive transfer of
Treg cells attenuated TP-induced liver injury accompanied
with decreasing infiltration of inflammatory cells in the
liver.
Depletion of Treg Aggravates
TP-induced Liver Injury
Administration of anti-CD25 antibodies and TP resulted
in significantly higher ALT and AST levels in serum
compared with the control group (Figures 2A,B).
Moreover, H&E staining demonstrated severer hepatocyte
necrosis and more inflammatory cell infiltration,
compared with mice administered TP alone (Figure 2C).
Mice administered the anti-CD25 antibodies alone
had no obvious histopathological changes in the liver
(Figure 2C).
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FIGURE 2 | Depletion of Tregs aggravates TP-induced liver injury. The mice were administered with purified anti-mouse CD25 antibody (200 µg/mouse; i.p.)
48 h before the TP administration, then underwent TP administration (500 µg/kg; i.g.) and sacrificed 24 h after TP administration. Changes of serum ALT (A) and
AST (B) levels were measured. Liver specimens were excised and fixed in 10% neutral-buffered formalin to generate tissue sections stained with H&E (C). The data
are shown as the mean ± SEM of six mice. ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001 vs. control. Black arrows shows necrosis and yellow arrows shows
inflammatory cell infiltration.
Adoptive Transfer of Tregs Modulates the
Treg/Th17 Balance in Favor of Treg Cells
Dominance
Mice treated with TP had significantly lower frequencies of
hepatic CD4+FoxP3+ cells (Figures 3A,B,E). Compared with the
TP-administration group, adoptive transfer of Treg cells notably
increased the frequencies of Treg cells in the liver (Figures 3D,E),
yet adoptive transfer of Teffs didn’t alter the percentage of hepatic
CD4+FoxP3+ cells (Figures 3C,E). Hepatic mRNA expressions
of FoxP3, which is required for Treg development, showed
tendencies to decrease in TP-administered mice (Figure 4A).
Th17 cells, another subset of CD4+ T lymphocytes, were
found to increase in TP-induced liver injury (Wang et al.,
2014b). The hepatic expressions of ROR-γt, which is essential
for Th17 cells differentiation, significantly increased after TP
administration (Figure 4B). Thus, adoptive transfer of Treg not
only significantly increased the hepatic mRNA expressions of
FoxP3, but also remarkably reduced the mRNA levels of ROR-
γt (Figures 4A,B). Adoptive transfer of Teffs didn’t change
the mRNA expression levels induced by TP. These findings
indicated that adoptive transfer of Treg contributed to regulation
of the Treg/Th17 balance in favor of Treg cells dominance,
which attenuated Th17 response and established a tolerance
environment in TP-induced liver injury.
Depletion of Treg Fails to Modulate the
Treg/Th17 Balance and Increases Th17
Cells Expression
The percentage of Treg cells significantly decreased in the
murine livers of TP and anti-CD25 co-administered mice
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FIGURE 3 | Adoptive transfer of Tregs increases hepatic percentages of Tregs. The mice were administered with CD4+CD25+Tregs or CD4+CD25−effector
T cells (1 × 106; i.v.) 24 h before TP administration, then underwent TP administration (500 µg/kg; i.g.) and sacrificed 24 h after TP administration. The percentage of
CD4+ FoxP3+ T cells in the liver was detected (A–D) and compared (E). The data are shown as the mean ± SEM of six mice. ∗P < 0.05 and ∗∗∗P < 0.001 vs.
control. #P < 0.05 vs. TP group.
FIGURE 4 | Adoptive transfer of Tregs alters hepatic Th17/Treg balance and serum IL-10 levels. The mice were administered with CD4+CD25+Tregs or
CD4+CD25−effector T cells (1 × 106; i.v.) 24 h before TP administration, then underwent TP administration (500 µg/kg; i.g.) and sacrificed 24 h after TP
administration. Relative expressions of FoxP3 (A), ROR-γt (B), and IL-10 (C) were measured by real-time RT-PCR and normalized to GAPDH mRNA. The serum
IL-10 level was measured by ELISA (D). The data are shown as the mean ± SEM of 6 mice. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs. control. #P < 0.05 and
###P < 0.001 vs. TP group.
compared with the TP-administrated mice (Figure 5).
Hepatic mRNA expression levels of FoxP3 significantly
reduced, while ROR-γt noticeably increased in TP and anti-
CD25 mAb co-administered mice (Figures 6A,B). These
results indicated that depletion of Treg resulted in failure to
modulate the Treg/Th17 balance and enhancement of Th17 cell
expression.
Adoptive Transfer of Treg Cells Enhance
IL-10 Secretion in Liver Tissue
Interleukin-10, mainly produced by Treg cells, plays an
important role in immune tolerance and anti-inflammation
(Sabat et al., 2010). The results showed the mRNA levels of IL-10
in TP-treated livers significantly decreased. Adoptive transfer of
Treg significantly increased the hepatic mRNA expressions of IL-
10 (Figure 4C), but adoptive transfer of Teffs didn’t change the
mRNA expression levels of IL-10 induce by TP. The serum IL-10
levels remarkably decreased 24 h after TP administration. Tregs-
pretreated mice had higher levels of IL-10, although it didn’t
show significant difference (Figure 4D). In addition, the serum
IL-10 levels in Teffs-treated mice didn’t significantly change
compared with TP group. These results indicated that hepatic
IL-10 contributed to Treg-mediated suppression of immune
response in TP-induced liver injury.
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FIGURE 5 | Depletion of Tregs decreases hepatic frequencies of Treg. The mice were administered with purified anti-mouse CD25 antibody (200 µg/mouse;
i.p.) 48 h before the TP administration, then underwent TP administration (500 µg/kg; i.g.) and sacrificed 24 h after TP administration. The percentage of CD4+
FoxP3+ T cells in the liver was detected (A–C) and compared (D). The data are shown as the mean ± SEM of six mice. ∗∗∗P < 0.001 vs. control and ##P < 0.01 vs.
TP group.
Depletion of Treg Diminishes IL-10
Secretion in Liver and Serum
Regulatory T-cell are likely to exhibit suppressive activity via
secreting inhibitory cytokines IL-10 (Shevach, 2009). Our data
showed not only hepatic mRNA expression levels of IL-10, but
also serum IL-10 levels significantly reduced in TP and anti-
CD25 mAb administered mice compared with the control group
(Figures 6C,D).
Adoptive Transfer of Tregs
Down-regulates the Expressions of
SOCS and Notch Signaling in TP-induced
Liver Injury
Suppressor of cytokine signaling is a negative regulator of STAT
pathway and can be significantly induced under pathophysiology
conditions in the liver (Yoshimura et al., 2007). The Notch
signaling pathway plays critical roles in T-cell development,
differentiation and liver homeostasis maintenance (Deftos and
Bevan, 2000). Hepatic mRNA levels of SOCS3, Notch1, Notch3,
Notch4, Jagged-1, Jagged-2, and Dll 4 significantly increased
after TP administration. Adoptive transfer of Tregs remarkably
inhibited the up-regulation of SOCS3, Notch1, and Notch3.
Moreover, Teffs didn’t change the gene expression levels induced
by TP (Figure 7). These results suggested that SOCS3, Notch1
and Notch 3 might affect Tregs, which might contribute to the
pathogenesis of TP-induced hepatotoxicity.
Depletion of Treg Up-regulates the
Expressions of SOCS and Notch
Signaling in TP-induced Liver Injury
Treg depletion further increased the gene expressions of SOCS1,
SOCS3, and Notch3 compared with TP-administered mice
(Figure 8). These results suggested that SOCS1, SOCS3, and
Notch 3 might modulate Tregs in the development of TP-induced
hepatotoxicity.
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FIGURE 6 | Depletion of Tregs alters hepatic Th17/Treg balance and serum IL-10 levels. The mice were administered with purified anti-mouse CD25
antibody (200 µg/mouse; i.p.) 48 h before the TP administration, then underwent TP administration (500 µg/kg; i.g.) and sacrificed 24 h after TP administration.
Relative expressions of FoxP3 (A), ROR-γt (B), and IL-10 (C) were measured by real-time RT-PCR and normalized to GAPDH mRNA. The serum IL-10 level was
measured by ELISA (D). The data are shown as the mean ± SEM of six mice. ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001 vs. control. #P < 0.05 vs. TP group.
DISCUSSION
Regulatory T cell can diminish potentially harmful immune
responses, including inhibiting T-cell proliferation and
blockading inflammatory cytokines release (Stockinger et al.,
2001). Tregs are engaged in a variety of liver disorders, such
as non-alcoholic fatty liver disease (Ma et al., 2007), ConA-
induced liver injury (Erhardt et al., 2007) and biliary atresia
(Liu et al., 2015). Tregs have reciprocal relationships with
pro-inflammatory Th17 cells in the liver (Wang et al., 2014a).
Th17 cell is a new lineage of CD4+T cell subset, which induces
the immune activation and is relevant to severity of liver injury
(Apostolidis et al., 2011). In the present study, adoptive transfer
of Treg not only significantly increased the hepatic mRNA
expressions of FoxP3, but also remarkably reduced the mRNA
levels of ROR-γt. These findings indicated that adoptive transfer
of Treg contributed to modulating the Treg/Th17 balance in
favor of Treg cells dominance, which attenuated Th17 response
and established a tolerance environment in TP-induced liver
injury. In contrast, depletion of Treg noticeably decreased
the hepatic mRNA levels of FoxP3 and increased the ROR-γt
expressions. Moreover, depletion of Treg resulted in immune
activation and aggravation of TP-induced hepatotoxicity. Thus,
Treg cells played important roles in maintaining homeostasis by
suppressing excessive immune response which otherwise would
result in serious liver injury.
Interleukin-10 is mainly produced by Treg cells to
exert effects on immune tolerance and anti-inflammation
(Shevach, 2009). The mRNA levels of IL-10 in TP-treated
livers significantly decreased, whereas adoptive transfer of
Treg significantly increased the expressions of IL-10 in liver
tissues. Moreover, depletion of Treg cell caused reduction
of hepatic IL-10 expression levels and serum IL-10 levels.
These observations indicated that IL-10, mainly produced
and regulated by Tregs, involved in TP-induced liver injury
model.
Level of certain enzyme, such as ALT and AST, in serum
can be monitored as a direct indicator of hepatocyte death
and liver injury. Adoptive transfer of Treg cells significantly
exhibited lower levels of ALT and AST in serum and attenuated
inflammatory cell infiltrating in liver tissues. However, depletion
of CD25+ cells showed aggravation of hepatotoxicity. From
these lines of evidence, explaining the immunological and
biological roles of hepatic Treg cells may contribute to
providing a potential strategy for managing TP-induced liver
injury.
Suppressor of cytokine signaling proteins are a family
of intracellular proteins that control cytokine signaling by
suppressing cytokine signal transduction process (Yoshimura
et al., 2007). The SOCS proteins, especially SOCS1 and SOCS3,
play an essential role in mediating inflammatory responses in
both immune cells and metabolic organs, such as liver (Galic
Frontiers in Pharmacology | www.frontiersin.org 8 April 2016 | Volume 7 | Article 99
fphar-07-00099 April 20, 2016 Time: 12:44 # 9
Wang et al. Treg in TP-induced Liver Injury
FIGURE 7 | Adoptive transfer of Tregs changes hepatic mRNA levels of SOCS signaling and Notch signaling. The mice were administered with
CD4+CD25+Tregs or CD4+CD25−effector T cells (1 × 106; i.v.) 24 h before TP administration, then underwent TP administration (500 µg/kg; i.g.) and sacrificed
24 h after TP administration. Relative expressions of SOCS signaling (A–C) and Notch signaling (D–L) were measured by real-time RT-PCR and normalized to
GAPDH mRNA. The data are shown as the mean ± SEM of six mice. ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001 vs. control. #P < 0.05 vs. TP group.
FIGURE 8 | Depletion of Tregs changes hepatic mRNA levels of SOCS signaling and Notch signaling. The mice were administered with purified anti-mouse
CD25 antibody (200 µg/mouse; i.p.) 48 h before the TP administration, then underwent TP administration (500 µg/kg; i.g.) and sacrificed 24 h after TP
administration. Relative expressions of SOCS signaling (A–C), Notch signaling (D–L) were measured by real-time RT-PCR and normalized to GAPDH mRNA. The
data are shown as the mean ± SEM of six mice. ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001 vs. control. #P < 0.05 and ###P < 0.001 vs. TP group.
et al., 2014). Conditional deletion of the SOCS3 gene revealed a
role for SOCS3 as a negative regulator of the Treg subset with
increased IL-10 and TGFβ production (Fitzgerald et al., 2009).
In the present study, SOCS3 expression significantly increased
in the liver after TP administration, which may be associated
with hepatic Treg reduction. Whereas adoptive transfer of Tregs
remarkably inhibited the expression of SOCS3, which may
contribute to Treg expansion in the liver. In addition, depletion
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of Treg cells further increased the mRNA levels of SOCS1 and
SOCS3 accompanied with more hepatic Treg reduction. The
findings indicate that SOCS proteins are target genes for immune
suppression induced by Treg cells.
The Notch signaling pathway is engaged in T cell development
and differentiation (Deftos and Bevan, 2000). In the liver, the
Notch pathway is indispensable for liver homeostasis (Morell
et al., 2013). FoxP3 has been demonstrated to be a downstream
target of Notch signaling in human cells and Notch1 signaling
is involved in Treg cell differentiation (Del Papa et al., 2013).
TP administration induced significant increase of hepatic mRNA
levels of Notch1, Notch3, Notch4, Jagged-1, Jagged-2, and Dll
4. Adoptive transfer of Tregs significantly inhibited the up-
regulation of Notch1 and Notch3, whereas Treg deficiency
further increased the gene expressions of Notch3. Overall, these
results revealed that Notch signaling contributed to the changes
of adoptive transfer or depletion Treg in TP-induced liver
injury.
In summary, the present study clearly demonstrated a potent
protective role of Tregs in TP-induced liver injury and this
protection may be mediated by enhancing the secretion of IL-
10. In addition, SOCS proteins and Notch signaling contributed
to the changes of adoptive transfer or depletion of Treg in
TP-induced liver injury. These findings may place Treg cells
as potential targets for pharmacotherapy, though the detailed
investigations on mechanism need to be carried out in the future.
AUTHOR CONTRIBUTIONS
XW, LZ, and ZJ designed the experiments. XW performed
the experiments. XW and ZJ analyzed and discussed the
data. XW, LS, LZ, and ZJ wrote the paper. All authors
contributed to the editing of the paper and to scientific
discussions.
FUNDING
The present study was supported by grants from the Natural
Science Foundation of Jiangsu Province (BK20151439)
and the National Natural Science Foundation of China
(No. 81573514, No. 81573690, No. 81173651, No.
81274146, No. 81102887, and No. 81320108029). The
study was partially supported by the 111 Project (No.
111-2-07).
ACKNOWLEDGMENT
We thank Professor Chen Yun for providing triptolide,
who is from the Dermatological Disease Research Institute
of the Chinese Academy of Medical Sciences (Nanjing,
China).
REFERENCES
Apostolidis, S. A., Crispin, J. C., and Tsokos, G. C. (2011). IL-17-producing
T cells in lupus nephritis. Lupus 20, 120–124. doi: 10.1177/0961203310
389100
Burghardt, S., Claass, B., Erhardt, A., Karimi, K., and Tiegs, G. (2014). Hepatocytes
induce Foxp3(+) regulatory T cells by Notch signaling. J. Leukoc. Biol. 96,
571–577. doi: 10.1189/jlb.2AB0613-342RR
Deftos, M. L., and Bevan, M. J. (2000). Notch signaling in T cell development. Curr.
Opin. Immunol. 12, 166–172. doi: 10.1016/S0952-7915(99)00067-9
Del Papa, B., Sportoletti, P., Cecchini, D., Rosati, E., Balucani, C., Baldoni, S., et al.
(2013). Notch1 modulates mesenchymal stem cells mediated regulatory T-cell
induction. Eur. J. Immunol. 43, 182–187. doi: 10.1002/eji.201242643
Doherty, D. G., and O’Farrelly, C. (2000). Innate and adaptive lymphoid cells in the
human liver. Immunol. Rev. 174, 5–20. doi: 10.1034/j.1600-0528.2002.017416.x
Erhardt, A., Biburger, M., Papadopoulos, T., and Tiegs, G. (2007). IL-10, regulatory
T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver
injury in mice. Hepatology 45, 475–485. doi: 10.1002/hep.21498
Fitzgerald, J. S., Toth, B., Jeschke, U., Schleussner, E., and Markert, U. R.
(2009). Knocking off the suppressors of cytokine signaling (SOCS): their
roles in mammalian pregnancy. J. Reprod. Immunol. 83, 117–123. doi:
10.1016/j.jri.2009.07.010
Fu, Q., Huang, X., Shu, B., Xue, M., Zhang, P., Wang, T., et al. (2011). Inhibition of
mitochondrial respiratory chain is involved in triptolide-induced liver injury.
Fitoterapia 82, 1241–1248. doi: 10.1016/j.fitote.2011.08.019
Galic, S., Sachithanandan, N., Kay, T. W., and Steinberg, G. R. (2014). Suppressor
of cytokine signalling (SOCS) proteins as guardians of inflammatory responses
critical for regulating insulin sensitivity. Biochem. J. 461, 177–188. doi:
10.1042/BJ20140143
Kim, J. M., Rasmussen, J. P., and Rudensky, A. Y. (2007). Regulatory T cells prevent
catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8,
191–197. doi: 10.1038/ni1428
Li, J., Qiu, S. J., She, W. M., Wang, F. P., Gao, H., Li, L., et al. (2012).
Significance of the balance between regulatory T (Treg) and T helper 17 (Th17)
cells during hepatitis B virus related liver fibrosis. PLoS ONE 7:e39307. doi:
10.1371/journal.pone.0039307
Li, Y., Yu, C., Zhu, W. M., Xie, Y., Qi, X., Li, N., et al. (2010). Triptolide
ameliorates IL-10-deficient mice colitis by mechanisms involving suppression
of IL-6/STAT3 signaling pathway and down-regulation of IL-17. Mol. Immunol.
47, 2467–2474. doi: 10.1016/j.molimm.2010.06.007
Liu, Q. (2011). Triptolide and its expanding multiple pharmacological functions.
Int. Immunopharmacol. 11, 377–383. doi: 10.1016/j.intimp.2011.01.012
Liu, Y. J., Li, K., Yang, L., Tang, S. T., Wang, X. X., Cao, G. Q., et al. (2015). Dendritic
cells regulate treg-Th17 axis in obstructive phase of bile duct injury in murine
biliary atresia. PLoS ONE 10:e0136214. doi: 10.1371/journal.pone.0136214
Ma, X., Hua, J., Mohamood, A. R., Hamad, A. R., Ravi, R., and Li, Z. (2007). A high-
fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver
injury. Hepatology 46, 1519–1529. doi: 10.1002/hep.21823
Morell, C. M., Fiorotto, R., Fabris, L., and Strazzabosco, M. (2013). Notch signalling
beyond liver development: emerging concepts in liver repair and oncogenesis.
Clin. Res. Hepatol. Gastroenterol. 37, 447–454. doi: 10.1016/j.clinre.2013.05.008
Pillemer, B. B., Xu, H., Oriss, T. B., Qi, Z., and Ray, A. (2007). Deficient
SOCS3 expression in CD4+CD25+FoxP3+ regulatory T cells and SOCS3-
mediated suppression of Treg function. Eur. J. Immunol. 37, 2082–2089. doi:
10.1002/eji.200737193
Radtke, F., Fasnacht, N., and Macdonald, H. R. (2010). Notch signaling in the
immune system. Immunity 32, 14–27. doi: 10.1016/j.immuni.2010.01.004
Sabat, R., Grutz, G., Warszawska, K., Kirsch, S., Witte, E., Wolk, K., et al. (2010).
Biology of interleukin-10. Cytokine Growth. Factor. Rev. 21, 331–344. doi:
10.1016/j.cytogfr.2010.09.002
Sennello, J. A., Fayad, R., Morris, A. M., Eckel, R. H., Asilmaz, E., Montez, J., et al.
(2005). Regulation of T cell-mediated hepatic inflammation by adiponectin and
leptin. Endocrinology 146, 2157–2164. doi: 10.1210/en.2004-1572
Shevach, E. M. (2009). Mechanisms of foxp3+ T regulatory cell-mediated
suppression. Immunity 30, 636–645. doi: 10.1016/j.immuni.2009.04.010
Stockinger, B., Barthlott, T., and Kassiotis, G. (2001). T cell regulation: a special
job or everyone’s responsibility? Nat. Immunol. 2, 757–758. doi: 10.1038/ni0
901-757
Frontiers in Pharmacology | www.frontiersin.org 10 April 2016 | Volume 7 | Article 99
fphar-07-00099 April 20, 2016 Time: 12:44 # 11
Wang et al. Treg in TP-induced Liver Injury
Stross, L., Gunther, J., Gasteiger, G., Asen, T., Graf, S., Aichler, M., et al.
(2012). Foxp3+ regulatory T cells protect the liver from immune damage and
compromise virus control during acute experimental hepatitis B virus infection
in mice. Hepatology 56, 873–883. doi: 10.1002/hep.25765
Tenorio, E. P., Olguin, J. E., Fernandez, J., Vieyra, P., and Saavedra, R.
(2010). Reduction of Foxp3+ cells by depletion with the PC61 mAb
induces mortality in resistant BALB/c mice infected with Toxoplasma
gondii. J. Biomed. Biotechnol. 2010, 786078. doi: 10.1155/2010/
786078
Wang, X., Jiang, Z., Cao, W., Yuan, Z., Sun, L., and Zhang, L. (2014a). Th17/Treg
imbalance in triptolide-induced liver injury. Fitoterapia 93, 245–251. doi:
10.1016/j.fitote.2014.01.006
Wang, X., Jiang, Z., Xing, M., Fu, J., Su, Y., Sun, L., et al. (2014b). Interleukin-17
mediates triptolide-induced liver injury in mice. Food Chem. Toxicol. 71, 33–41.
doi: 10.1016/j.fct.2014.06.004
Wang, X., Zhang, L., and Jiang, Z. (2015). T-helper cell-mediated factors in
drug-induced liver injury. J. Appl. Toxicol. 35, 695–700. doi: 10.1002/jat.3115
Yagi, H., Nomura, T., Nakamura, K., Yamazaki, S., Kitawaki, T., Hori, S.,
et al. (2004). Crucial role of FOXP3 in the development and function of
human CD25+CD4+ regulatory T cells. Int. Immunol. 16, 1643–1656. doi:
10.1093/intimm/dxh165
Yoshimura, A., Naka, T., and Kubo, M. (2007). SOCS proteins, cytokine signalling
and immune regulation. Nat. Rev. Immunol. 7, 454–465. doi: 10.1038/
nri2093
Zhou, G. S., Hu, Z., Fang, H. T., Zhang, F. X., Pan, X. F., Chen, X. Q., et al. (2011).
Biologic activity of triptolide in t(8;21) acute myeloid leukemia cells. Leuk. Res.
35, 214–218. doi: 10.1016/j.leukres.2010.07.013
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Wang, Sun, Zhang and Jiang. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Pharmacology | www.frontiersin.org 11 April 2016 | Volume 7 | Article 99
